Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-13 Cr₹1.01 Cr₹-15 Cr₹-44 Cr₹130 Cr

What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH is ₹-13 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-13 Cr
Mar2025₹1.01 Cr
Mar2024₹-15 Cr
Mar2023₹-44 Cr
Mar2022₹130 Cr

How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-13 Cr
Negative
Mar2025 ₹1.01 Cr
Positive
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹-44 Cr
Negative
Mar2022 ₹130 Cr -

Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,132.5 Cr -5.4% -8.3% 12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,120.0 Cr -3.2% -5.4% 12% Stock Analytics
DIVIS LABORATORIES ₹253,390.0 Cr 0.7% 3.2% 61.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,740.0 Cr -2.8% -3% 32.6% Stock Analytics
CIPLA ₹108,497.0 Cr -2.9% -3.3% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,925.0 Cr -3.3% 4.7% -2.2% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-5.4%

-8.3%

12.1%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses